Gene · 762
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization. | Int J Mol Sci | 2022 | 35409361 | PubTator, text mining | PubMed |
| Applying Protein-Protein Interactions and Complex Networks to Identify Novel Genes in Retinitis Pigmentosa Pathogenesis. | Int J Mol Sci | 2022 | 35409321 | PubTator, text mining | PubMed |
| The Inverse Association of Sarcopenia and Protein-Source Food and Vegetable Intakes in the Korean Elderly: The Korean Frailty and Aging Cohort Study. | Nutrients | 2022 | 35405986 | PubTator, text mining | PubMed |
| Concise synthesis and preliminary biological evaluation of new triazolylthioacetone derivatives bearing pyridine, pyrazine, and 3,4,5-trimethoxybenzyl fragment. | Bioorg Med Chem Lett | 2022 | 35398303 | PubTator, text mining | PubMed |
| The Presence of the Temporal Horn Exacerbates the Vulnerability of Hippocampus During Head Impacts. | Front Bioeng Biotechnol | 2022 | 35392406 | PubTator, text mining | PubMed |
| Development of a Bead-Based Multiplex Assay for Use in Multianalyte Screening and Surveillance of HIV, Viral Hepatitis, Syphilis, and Herpes. | J Clin Microbiol | 2022 | 35387497 | PubTator, text mining | PubMed |
| Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors. | Bioorg Chem | 2022 | 35366582 | PubTator, text mining | PubMed |
| The Pharmacological Mechanisms of Xiaochaihutang in Treating Breast Cancer Based on Network Pharmacology. | Contrast Media Mol Imaging | 2022 | 35350700 | PubTator, text mining | PubMed |
| The surprising effects of sulfur: achieving long excited-state lifetimes in heteroleptic copper(i) emitters. | J Mater Chem C Mater | 2022 | 35340713 | PubTator, text mining | PubMed |
| The Regulatory Role of Neuropeptide Gene Glucagon in Colorectal Cancer: A Comprehensive Bioinformatic Analysis. | Dis Markers | 2022 | 35340411 | PubTator, text mining | PubMed |
| Discovery of pyrimidine-bridged CA-4 CBSIs for the treatment of cervical cancer in combination with cisplatin with significantly reduced nephrotoxicity. | Eur J Med Chem | 2022 | 35339837 | PubTator, text mining | PubMed |
| Rethinking Protein Drug Design with Highly Accurate Structure Prediction of Anti-CRISPR Proteins. | Pharmaceuticals (Basel) | 2022 | 35337108 | PubTator, text mining | PubMed |
| A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling. | Nat Cell Biol | 2022 | 35332263 | PubTator, text mining | PubMed |
| Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer's Disease. | J Clin Med | 2022 | 35329851 | PubTator, text mining | PubMed |
| High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer. | Cancers (Basel) | 2022 | 35326703 | PubTator, text mining | PubMed |
| Changes in Hippocampus and Amygdala Volume with Hypoxic Stress Related to Cardiorespiratory Fitness under a High-Altitude Environment. | Brain Sci | 2022 | 35326315 | PubTator, text mining | PubMed |
| KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors. | Mol Oncol | 2022 | 35313064 | PubTator, text mining | PubMed |
| LncSNHG1 Promoted CRC Proliferation through the miR-181b-5p/SMAD2 Axis. | J Oncol | 2022 | 35310912 | PubTator, text mining | PubMed |
| Low Subicular Volume as an Indicator of Dementia-Risk Susceptibility in Old Age. | Front Aging Neurosci | 2022 | 35309894 | PubTator, text mining | PubMed |
| The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. | J Enzyme Inhib Med Chem | 2022 | 35306936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/762/papers?page=27